Implanet S.A. (EPA:ALIMP)

Market Cap	25.62M +70.9%
Revenue (ttm)	11.10M +52.1%
Net Income	-4.81M
EPS	-0.04
Shares Out	125.60M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	387,509
Average Volume	116,287
Open	0.2140
Previous Close	0.2110
Day's Range	0.1990 - 0.2140
52-Week Range	0.0800 - 0.4500
Beta	0.73
RSI	33.09
Earnings Date	Feb 24, 2026

About Implanet

Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products, including Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, and Jazz Frame, as well as ISS-Jazz Screw systems for posterior fixation. It also provides ultrasonic osteotomy surgical system; and knee prostheses under the Madison name. The company exports its products. Implanet S....

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Employees: 46
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALIMP

Financial Performance

In 2024, Implanet's revenue was 9.41 million, an increase of 26.31% compared to the previous year's 7.45 million. Losses were -4.37 million, -34.60% less than in 2023.